Eisai Establishes Sales Subsidiary in Sweden.
Tokyo, Japan, July 14, 2005 - (JCNN JCNN Japan Corporate News Network ) - Eisai (TSE See Tokyo Stock Exchange.
TSE
1. See Tokyo Stock Exchange (TSE).
2. See Toronto Stock Exchange (TSE). : 4523) has announced the July 8 establishment of Eisai AB, a new sales company in Sweden. Capitalized at 150 million yen ($1.3 mil), Eisai AB will serve as a sales base in the Nordic market (Sweden, Denmark, Finland and Norway).
Specifically, the new company, a subsidiary of Eisai's group company Eisai Europe Limited., plans to promote products in the field of neurology neurology (n rŏl`əjē, ny–), study of the morphology, physiology, and pathology of the human nervous system. , including Eisai's proprietary antiepileptic agents Zonegran and Inovelon.
Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion